Provigil Pay-For-Delay Suit Survives Reconsideration Bid
A Pennsylvania federal judge on Friday declined to reconsider his ruling that a handful of pay-for-delay suits against drugmaker Cephalon Inc. over its Provigil narcolepsy drug meets the U.S. Supreme Court's...To view the full article, register now.
Already a subscriber? Click here to view full article